B Cells (B Lymphocytes)

B Cells (B Lymphocytes)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">B Cells (B Lymphocytes)</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000236](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000236)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000236](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000236)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000969](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000969)</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Rituximab</td>
<td>CD20</td>
</tr>
<tr>
<td class="label">Ocrelizumab</td>
<td>CD20</td>
</tr>
<tr>
<td class="label">Belimumab</td>
<td>BAFF</td>
</tr>
<tr>
<td class="label">Abciximab</td>
<td>Glycoprotein IIb/IIIa</td>
</tr>
</table>

Introduction

B Cells (B Lymphocytes) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

...

B Cells (B Lymphocytes)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">B Cells (B Lymphocytes)</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000236](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000236)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000236](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000236)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000969](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000969)</td>
</tr>
<tr>
<td class="label">Drug</td>
<td>Target</td>
</tr>
<tr>
<td class="label">Rituximab</td>
<td>CD20</td>
</tr>
<tr>
<td class="label">Ocrelizumab</td>
<td>CD20</td>
</tr>
<tr>
<td class="label">Belimumab</td>
<td>BAFF</td>
</tr>
<tr>
<td class="label">Abciximab</td>
<td>Glycoprotein IIb/IIIa</td>
</tr>
</table>

Introduction

B Cells (B Lymphocytes) is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

B cells (B lymphocytes) are adaptive immune cells that play critical roles in humoral immunity through antibody production. While traditionally studied in peripheral immunology, emerging research reveals important roles for B cells and humoral immunity in neurodegenerative diseases. [@wang2021]

Overview

B cells are produced and matured in the bone marrow, where they develop antigen receptors (B cell receptors/BCRs). Upon encountering antigen, B cells differentiate into plasma cells (antibody-secreting cells) and memory B cells. [@fiala2020]

Key Surface Markers

• CD19 - pan-B cell marker
• CD20 - therapeutic target (rituximab)
• CD21 - complement receptor
• CD27 - memory B cell marker
• IgM/IgD - surface immunoglobulin

<!-- taxonomy-enrichment --> [@lund2023]

<!-- multi-taxonomy-enrichment --> [@balkema2021]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000236)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000236)
• [OBO Foundry (CL:0000236)](http://purl.obolibrary.org/obo/CL_0000236)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000236)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000236)
• [OBO Foundry (CL:0000236)](http://purl.obolibrary.org/obo/CL_0000236)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Functions in Adaptive Immunity

Antibody Production

• Neutralizing antibodies - block pathogens and toxins
• Opsonizing antibodies - enhance phagocytosis
• Complement-activating antibodies - initiate complement cascade

Antigen Presentation

B cells present antigens to T cells via MHC class II, bridging innate and adaptive immunity.

Cytokine Production

B cells secrete regulatory cytokines including:

• IL-6 - inflammation and B cell differentiation
• IL-10 - anti-inflammatory effects
• TNF-α - pro-inflammatory signaling
• IFN-γ - Th1 polarization

B Cells in Neurodegeneration

Alzheimer's Disease

Autoantibodies in AD

• Patients show elevated autoantibodies against neural antigens
• Anti-amyloid antibodies (natural and therapeutic)
• Anti-tau antibodies in cerebrospinal fluid
• Antibodies to neuronal surface antigens

B Cell Infiltration

• B cells found in AD brain parenchyma
• Perivascular B cell aggregates in leptomeninges
• Tertiary lymphoid structures in AD dura

Therapeutic Approaches

• Anti-Aβ antibodies (aducanumab, lecanemab, donanemab)
• Passive immunization strategies
• B cell depletion (rituximab) trials

Parkinson's Disease

Humoral Autoimmunity

• Elevated anti-α-synuclein antibodies
• Autoantibodies against dopamine neurons
• Cross-reactive antibodies (molecular mimicry)

B Cell Findings

• Altered B cell repertoire in PD
• Elevated BAFF (B cell activating factor)
• Intrathecal IgG synthesis

Amyotrophic Lateral Sclerosis

Antibody Involvement

• Anti-neuronal antibodies in ALS patients
• Antibodies against voltage-gated calcium channels
• Anti-GM1 antibodies (motor neuron reactivity)

Immune Dysregulation

• Altered B cell subsets in ALS
• Elevated serum IgG levels
• CSF oligoclonal bands in some patients

Multiple Sclerosis

While primarily demyelinating, MS shares features with neurodegeneration:

• B cell infiltration in lesions
• Oligoclonal IgG bands in CSF
• Anti-myelin antibodies
• B cell depletion therapies effective (ocrelizumab)

CNS B Cell Functions

Peripheral vs CNS B Cells

• Systemic B cells - produce serum antibodies
• CNS-infiltrating B cells - localized immune response
• Meningeal B cells - tertiary lymphoid organs

Antibody Transport

• IgG transport across blood-brain barrier via FcRn receptor
• Differential IgG subclass distribution in CSF
• Polyclonal vs monoclonal antibody patterns

Therapeutic Implications

B Cell-Targeting Therapies

Immunomodulation

• BAFF inhibition (belimumab, tabalumab)
• IL-6 receptor blockade (tocilizumab)
• Costimulatory blockade
• T Cells
• [Microglia](/cell-types/microglia) Neuroinflammation
• Adaptive Immunity
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrop- [Blood-Brain Barrier](/mechanisms/blood-brain-barrier))
• [Blood-Brain Barrier](/mechanisms/blood-brain-barrier)

Background

The study of B Cells (B Lymphocytes) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data